Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making
2 other identifiers
observational
136
1 country
1
Brief Summary
Preventing cervical cancer is a public health concern. Since 2006 a quadrivalent vaccine for young women nine to twenty six years of age has been available to protect against the human papillomavirus (HPV) and to prevent some types of cervical cancer (Gardasil). The vaccine is an important health promotion tool to address the widespread prevalence of HPV and cervical cancer, but not all eligible young women receive the vaccine. The vaccine is most effective when administered to young women before their sexual debut. When the vaccine is given to young women less than 18 years of age, parental permission is required. This permission is usually provided by the young woman's mother. Understanding predictors of a mother's decision for her minor daughter to receive the HPV vaccine will inform interventions that seek to increase the number of young women who receive the vaccine. The study will focus on mothers and their adolescent daughters between 13-17 years of age. We hypothesize that the Expanded Theory of Planned Behavior will explain a mother's decision to choose the HPV vaccine for her daughter. Research Questions include: 1)What TPB variables predict a mother's decision to choose HPV vaccine for her daughter? 2)What variables predict the strength of a daughter's influence on the mother's decision to choose HPV vaccine for her daughter? 3) What are the relationships between the mothers' and daughters' scores on the variables related to the decision to choose HPV vaccine? 4) How do the mothers and daughters who chose to receive the HPV vaccine differ descriptively from those mothers and daughters who do not choose to receive the HPV vaccine?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2008
CompletedFirst Posted
Study publicly available on registry
December 12, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedMay 5, 2017
January 1, 2011
1.9 years
December 11, 2008
May 2, 2017
Conditions
Keywords
Eligibility Criteria
Mother and daughter pairs (n =75) will be recruited.
You may qualify if:
- Adolescent females 13-17 years of age
- and adolescent's mother, any age
- and adolescent not pregnant
- and adolescent has not received vaccine for HPV
You may not qualify if:
- Males
- daughters younger than 13 yrs of age
- daughters older than 17 yrs of age
- pregnant daughters
- daughters who have received the HPV vaccine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Louisvillelead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
University of Louisville School of Nursing
Louisville, Kentucky, 40292, United States
Related Publications (1)
Hertweck SP, LaJoie AS, Pinto MD, Flamini L, Lynch T, Logsdon MC. Health care decision making by mothers for their adolescent daughters regarding the quadrivalent HPV vaccine. J Pediatr Adolesc Gynecol. 2013 Apr;26(2):96-101. doi: 10.1016/j.jpag.2012.10.009.
PMID: 23518189DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mimia C Logsdon, DNS, ARNP, FAAN
University of Louisville School of Nursing
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 11, 2008
First Posted
December 12, 2008
Study Start
January 1, 2009
Primary Completion
December 1, 2010
Study Completion
January 1, 2011
Last Updated
May 5, 2017
Record last verified: 2011-01